CMS Launches Office of Health Technology to Enhance Digital Health
The Centers for Medicare & Medicaid Services (CMS) has inaugurated the Office of Health Technology and Products to enhance its technological capabilities and encourage digital health solutions. This strategic move focuses on centralizing efforts to foster data sharing and streamline digital health adoption. The office, set to reorganize at the end of June, will comprise eight subgroups, each dedicated to specific technology functions such as public-facing services and interoperability policies.
One key component is the Open Source Program Group, which aims to integrate successful technology practices from private sector partners. By enlisting software engineers and product managers, this group will enhance CMS's technological arsenal. The Standards and Interoperability Group is tasked with guiding data exchange strategies, creating interoperable solutions through its Division of Data and Interoperability Platforms. This includes developing critical tools like application programming interfaces (APIs) and data exchange platforms. The Division of Policy will concurrently draft and enforce regulations related to interoperability.
The office will also oversee product development, with divisions managing CMS’s core platforms and beneficiary-centric tools. CMS’s Digital Service will handle shorter-term projects targeting critical healthcare issues, focusing on supporting at-risk populations and enhancing operational efficiency. This aligns with ongoing efforts to modernize healthcare delivery using technology.
In alignment with recent initiatives, CMS launched the Health Tech Ecosystem to partner with leading health and tech firms, advancing data sharing and digital health offerings. This initiative introduced numerous tools and expanded efforts to simplify electronic prior authorization processes. Such advancements are expected to streamline interactions between payers and providers, ultimately benefiting the insured community.
Moreover, CMS's innovation center unveiled a payment model aimed at improving access to technology-assisted chronic care management. This model offers fixed reimbursements to participants, including digital health companies, for managing Medicare beneficiaries with chronic conditions such as diabetes and hypertension.
Additionally, the Food and Drug Administration (FDA) has acted to ensure drug advertisements comply with federal standards, aiming for a balanced presentation of risks and benefits. In another move to strengthen oversight, CMS is investing in technology and expanding its coding workforce to increase audits and resolve its backlog of Medicare Advantage plan reviews.
Legislative momentum is building around the practices of pharmacy benefit managers (PBMs), with senators contemplating regulatory changes following the passage of significant legislation. Industry professionals should stay informed on these developments to navigate the evolving insurance landscape effectively.